KIIL HARRY SKIP 4

4 · Medtronic plc · Filed Jul 30, 2025

Form 4

Period: 2025-07-28

EVP & President Cardiovascular

Transactions

Award
Performance Share Units
2025-07-28+19,028→ 19,028 total
→ Performance Share Unit (19,028 underlying)
Award
Stock Option (Right to Buy)
2025-07-28+53,671→ 53,671 total
Exercise: $91.97Exp: 2035-07-28→ Ordinary Shares (53,671 underlying)
Award
Ordinary Shares
2025-07-28+7,612→ 41,318 total

Footnotes (6)

[F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
[F2]Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person.
[F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F4]Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
[F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,028 shares will be issued. If maximum performance metrics are achieved, 38,056 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
[F6]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Documents

1 file